Tesla
TSLA
NVIDIA
NVDA
Alibaba
BABA
4
Super Micro Computer
SMCI
5
Palantir
PLTR
US Stock MarketDetailed Quotes
ADIL Adial Pharmaceuticals
- 0.9229
- +0.1579+20.64%
Close Feb 25 16:00 ET
- 0.8201
- -0.1028-11.14%
Post 19:59 ET
5.98MMarket Cap-0.28P/E (TTM)
1.3000High0.8100Low42.63MVolume0.9485Open0.7650Pre Close45.30MTurnover707.81%Turnover RatioLossP/E (Static)6.47MShares3.600052wk High1.02P/B5.56MFloat Cap0.715152wk Low--Dividend TTM6.02MShs Float236.0000Historical High--Div YieldTTM64.05%Amplitude0.7151Historical Low1.0620Avg Price1Lot Size
Adial Pharmaceuticals News
4: Statement of changes in beneficial ownership of securities-Officer Claiborne Cary J
4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay
3: Initial statement of beneficial ownership of securities-Officer Shah Vinay
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gilliland Robertson H.
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Newman James W. Jr.
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Truluck Joseph
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Claiborne Cary J
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Anderson J. Kermit
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schuyler Kevin
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goodman Tony
Adial Pharmaceuticals | D: Filing D
Adial Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Adial Pharmaceuticals | D: Filing D
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schuyler Kevin
Adial Pharmaceuticals | D: Filing D
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Johnson Bankole A.
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Truluck Joseph
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Stilley William B. III
Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schuyler Kevin